Comparison of procalcitonin and C-reactive protein tests in children with urinary tract infection

Iranian Journal of Pediatrics

Volumn 19, Issue 4, 2009, Pages 381-386

  Ayazi, Parviz ^a   Mahyar, Abolfazl ^a   Hashemi, Hassan Jahani ^a   Daneshi, Mohammad Mahdi ^a   Karimzadeh, Toktam ^a   Salimi, Fatemeh ^a  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Children; Procalcitonin; Pyelonephritis; Serum marker; UTI

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; SUCCIMER TC 99M;

ARTICLE; BLOOD SAMPLING; CHILD; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HUMAN; INFANT; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; URINARY TRACT INFECTION;

EID: 73949098891     PISSN: 10184406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Prat C, Domínguez J, Rodrigo C, et al. Elevated serum procalcitonin values correlate with renal scarring in children with urinary tract infection. Pediatr Infect Dis J. 2003;22(5):438-42.
2. Benador D, Benador N, Slosman D, et al. Are younger children at highest risk of renal sequelae after pyelonephritis? The Lancet. 1997;349(9044):17-9.
3. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Pediatrics. 1999;103(4 pt 1):843-52.
4. Gervaix A, Galetto-Lacour A, Gueron T, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J. 2001;20(5):507-11.
5. Jacobson SH, Eklöf O, Eriksson CG, et al. Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up. BMJ, 1989;299(6701):703-6.
6. Smellie JM, Poulton A, Prescod NP. Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ. 1994;308(6938):1193-6.
7. Johnson CE. New advances in childhood urinary tract infections. Pediatr Rev. 1999;20(10):335-42.
8. Benador N, Siegrist CA, Gendrel D, et al. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics. 1998;102(6):1422-5.
9. Hatherill M, Tibby SM, Sykes K, et al. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leukocyte count. Arch Dis Child. 1999;81(5):417-21.
10. Hedlund J, Hansson LO. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection. 2000;28(2):68-73.
11. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997;16(8):735-46.
12. Morgan MG, McKenzie H. Controversies in the laboratory diagnosis of community-acquired urinary tract infection. Eur J Clin Microbiol Infect Dis. 1993;12(7):491-504.
13. th ed. Churchill Livingstone, London, 2001; Pp:528-9.
14. th ed. Philadelphia; Saunders, 2004; Pp:1758-9.
15. Benador D, Benador N, Slosman DO, et al. Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis. J Pediatr. 1994;124(1):17-20.
16. Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999;104(1 pt1):79-86.
17. Pecile P, Miorin E, Romanello C, et al. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics. 2004;114(2):e249-54.
18. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children without localizing signs of infection seen in a referral center. Pediatrics. 2003;112(5): 1054-60.